Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer

Published:2020-09 Issue: Volume:136 Page:16-24
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

van der Doelen Maarten J.,Isaacsson Velho Pedro,Slootbeek Peter H.J.,Pamidimarri Naga Samhita,Bormann Maren^ORCID,van Helvert Sjoerd,Kroeze Leonie I.,van Oort Inge M.,Gerritsen Winald R.,Antonarakis Emmanuel S.,Mehra Niven^ORCID

Funder

NGS

Bayer

Janssen-Cilag

Astellas

Sanofi

MSD

Genzyme

Pfizer

AstraZeneca

Merck

Johnson & Johnson

Genentech, San Francisco, California, USA

Novartis

Amgen

E.S.A.

NIH

Cancer Center

Cilag

Roche

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Alpha emitter radium-223 and survival in metastatic prostate cancer;Parker;N Engl J Med,2013

3. Radium-223 inhibits osseous prostate cancer growth by dual targeting of cancer cells and bone microenvironment in mouse models;Suominen;Clin Cancer Res,2017

4. The DNA damage response and cancer therapy;Lord;Nature,2012

5. Prognostic and therapeutic implications of DNA repair gene mutations in advanced prostate cancer;Schweizer;Clin Adv Hematol Oncol,2017

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Activity of DNA Damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer;Cancers;2024-04-15

2. Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study;European Urology Oncology;2024-04

3. Case report: Exceptional and durable response to Radium-223 and suspension of androgen deprivation therapy in a metastatic castration-resistant prostate cancer patient;Frontiers in Oncology;2024-03-08

4. DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair;Pharmaceutics;2023-12-12

5. PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness;The Prostate;2023-11-14